DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Zyprexa (Olanzapine) - Hypertension - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Hypertension (68)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Zyprexa (Olanzapine) where reactions include hypertension. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 68   Next >>

Possible Zyprexa side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-06

Patient: male

Reactions: Movement Disorder, Weight Decreased, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Injury, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Dystonia, Grimacing, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Suicide Attempt, Disturbance in Attention, Tardive Dyskinesia, Extrapyramidal Disorder, Gait Disturbance, Hypertension

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: ndc 050468-306
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02

Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Risperdal Consta
    Indication: Major Depression
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Zyprexa
    Indication: Schizophrenia

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Indication: Bipolar Disorder
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01



Possible Zyprexa side effects in male

Reported by a consumer/non-health professional from France on 2012-08-03

Patient: male

Reactions: Mydriasis, Respiratory Disorder, Central Nervous System Lesion, Ischaemic Stroke, Cerebellar Syndrome, Cerebellar Haematoma, Bladder Dilatation, Pulmonary Congestion, Depression, Hypertension, Deep Vein Thrombosis

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Zyprexa

Other drugs received by patient: Risperdal; Polyethylene Glycol; Tercian; Loxapine HCL; Risperdal Consta; Escitalopram; Risperdal; Lepticur; Imovane



Possible Zyprexa side effects in female

Reported by a consumer/non-health professional from Japan on 2012-08-02

Patient: female

Reactions: Maternal Drugs Affecting Foetus, Hellp Syndrome, Exposure During Breast Feeding, Hypertension

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cymbalta
    Dosage: 20 mg, unk
    Administration route: Oral
    Start date: 2012-04-25
    End date: 2012-07-03

Cymbalta
    Dosage: 20 mg, unk
    Administration route: Oral
    Indication: Bipolar Disorder
    Start date: 2011-02-23
    End date: 2011-03-08

Cymbalta
    Dosage: 40 mg, unk
    Administration route: Oral
    Start date: 2012-03-28
    End date: 2012-04-24

Cymbalta
    Dosage: 40 mg, unk
    Administration route: Oral
    Start date: 2011-03-09
    End date: 2011-03-22

Zyprexa
    Dosage: 20 mg, unk
    Administration route: Oral
    Indication: Bipolar Disorder
    Start date: 2011-01-23
    End date: 2011-09-05

Cymbalta
    Dosage: 60 mg, unk
    Administration route: Oral
    Start date: 2011-03-23
    End date: 2012-03-01

Cymbalta
    Dosage: 40 mg, unk
    Administration route: Oral
    Start date: 2012-07-04

Other drugs received by patient: Loramet; Sediel; Goodmin; Amoban; Seroquel; Alprazolam; Sepazon



Possible Zyprexa side effects in 19 year old male

Reported by a physician from Switzerland on 2012-07-31

Patient: 19 year old male

Reactions: Agitation, Yawning, Hallucination, Auditory, Dementia, Tachycardia, Hypotension, Opisthotonus, Encephalopathy, Abnormal Behaviour, Speech Disorder, Bradycardia, Gait Disturbance, Altered State of Consciousness, Hypertension, Acute Disseminated Encephalomyelitis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Zyprexa

Other drugs received by patient: Haloperidol; Haloperidol



Possible Zyprexa side effects in 42 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-26

Patient: 42 year old female

Reactions: Type 2 Diabetes Mellitus, Vision Blurred, Hypertension, Metabolic Syndrome

Drug(s) suspected as cause:
Risperdal
    Start date: 2006-07-01
    End date: 2007-01-01

Zyprexa
    Indication: Mental Disorder
    Start date: 1998-12-01
    End date: 2006-06-01

Risperdal
    Indication: Schizophrenia
    Start date: 1994-11-23

Zyprexa
    Start date: 2000-02-08

Seroquel
    Dosage: 100 mg to 400 mg daily
    Administration route: Oral
    Start date: 1999-10-13

Seroquel
    Dosage: 25mg, 100mg, 200mg and 300mg
    Administration route: Oral
    Start date: 2000-10-01
    End date: 2002-03-01

Other drugs received by patient: Ranitidine; Tricor; Vesicare; Klonopin; Ranitidine; Niaspan; Lithium Carbonate; Cogentin; Mavik; Lisinopril; Enalapril Maleate; Aspirin; Paxil; Lithobid



Possible Zyprexa side effects in 81 year old male

Reported by a consumer/non-health professional from Mexico on 2012-07-25

Patient: 81 year old male

Reactions: Pneumonia, Cardio-Respiratory Arrest, Hypertension

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Zyprexa

Other drugs received by patient: Analgesics; Antibiotics; Midazolam



Possible Zyprexa side effects in female

Reported by a consumer/non-health professional from Japan on 2012-07-18

Patient: female

Reactions: Maternal Drugs Affecting Foetus, Hellp Syndrome, Exposure During Breast Feeding, Hypertension

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cymbalta
    Dosage: 20 mg, unk
    Administration route: Oral
    Indication: Bipolar Disorder
    Start date: 2011-02-23
    End date: 2011-03-08

Cymbalta
    Dosage: 40 mg, unk
    Administration route: Oral
    Start date: 2012-03-28
    End date: 2012-04-24

Cymbalta
    Dosage: 40 mg, unk
    Administration route: Oral
    Start date: 2011-03-09
    End date: 2011-03-22

Cymbalta
    Dosage: 20 mg, unk
    Administration route: Oral
    Start date: 2012-04-25
    End date: 2012-07-03

Zyprexa
    Dosage: 20 mg, unk
    Administration route: Oral
    Indication: Bipolar Disorder
    Start date: 2011-01-23
    End date: 2011-09-05

Cymbalta
    Dosage: 60 mg, unk
    Administration route: Oral
    Start date: 2011-03-23
    End date: 2012-03-01

Cymbalta
    Dosage: 40 mg, unk
    Administration route: Oral
    Start date: 2012-07-04

Other drugs received by patient: Seroquel; Sepazon; Goodmin; Alprazolam; Loramet; Sediel; Amoban



Possible Zyprexa side effects in female

Reported by a physician from Croatia (Local Name: Hrvatska) on 2012-07-11

Patient: female, weighing 100.0 kg (220.0 pounds)

Reactions: Off Label Use, Tachycardia, Pulmonary Oedema, General Physical Health Deterioration, Hypertension, Cardiac Failure Congestive

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Zyprexa

Other drugs received by patient: Equanil; Lanitop; Diazepam; Depakene; Zonadin; Iruzid / 06400701 /



Possible Zyprexa side effects in male

Reported by a consumer/non-health professional from United States on 2012-07-03

Patient: male

Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Injury, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Disturbance in Attention, Suicide Attempt, Tardive Dyskinesia, Gait Disturbance, Extrapyramidal Disorder, Hypertension

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Risperdal Consta
    Indication: Bipolar Disorder
    Start date: 2009-01-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02

Zyprexa
    Indication: Schizophrenia

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Indication: Major Depression
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: ndc 050468-306
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-04-07
    End date: 2011-02-02



Possible Zyprexa side effects in male

Reported by a physician from United States on 2012-06-26

Patient: male

Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Injury, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Abnormal Behaviour, Condition Aggravated, Torticollis, Muscle Twitching, Dissociation, Suicide Attempt, Disturbance in Attention, Gait Disturbance, Extrapyramidal Disorder, Tardive Dyskinesia, Hypertension

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2009-01-01

Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Risperdal Consta
    Indication: Major Depression
    Start date: 2010-04-01
    End date: 2010-08-01

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Dosage: ndc 050468-306
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Zyprexa
    Indication: Schizophrenia

Risperdal Consta
    Indication: Bipolar Disorder
    Start date: 2009-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01



Possible Zyprexa side effects in male

Reported by a physician from United States on 2012-06-05

Patient: male

Reactions: Movement Disorder, Weight Decreased, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Injury, Muscle Spasms, Inappropriate Schedule of Drug Administration, Back Pain, Dysphagia, Dystonia, Grimacing, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Gait Disturbance, Extrapyramidal Disorder, Tardive Dyskinesia, Hypertension

Drug(s) suspected as cause:
Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02

Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Indication: Bipolar Disorder
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: ndc 050468-306
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Indication: Major Depression
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Zyprexa
    Indication: Schizophrenia



Possible Zyprexa side effects in male

Reported by a physician from United States on 2012-05-31

Patient: male

Reactions: Movement Disorder, Weight Decreased, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Gait Disturbance, Tardive Dyskinesia, Extrapyramidal Disorder, Hypertension

Drug(s) suspected as cause:
Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2009-01-01

Zyprexa
    Indication: Schizophrenia

Risperdal Consta
    Indication: Major Depression
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Indication: Bipolar Disorder
    Start date: 2009-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-04-07
    End date: 2011-02-02



Possible Zyprexa side effects in female

Reported by a consumer/non-health professional from France on 2012-05-29

Patient: female

Reactions: Confusional State, Abnormal Behaviour, Fall, Hypertension

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Zyprexa
    Dosage: 5 mg, qd
    Start date: 2012-01-24

Zyprexa
    Dosage: 5 mg, qd
    Administration route: Oral
    Start date: 2012-01-11
    End date: 2012-01-20

Other drugs received by patient: Acetaminophen; Vitamin D; Mirtazapine; Aspirin; Moviprep; Memantine Hydrochloride; Imovane; Escitalopram; Oxazepam; Furadantin; Memantine Hydrochloride



Possible Zyprexa side effects in male

Reported by a consumer/non-health professional from United States on 2012-05-15

Patient: male

Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Dystonia, Grimacing, Abnormal Behaviour, Condition Aggravated, Torticollis, Muscle Twitching, Dissociation, Gait Disturbance, Tardive Dyskinesia, Extrapyramidal Disorder, Hypertension

Drug(s) suspected as cause:
Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Indication: Major Depression
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Zyprexa
    Indication: Schizophrenia

Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: ndc 050468-306
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Indication: Bipolar Disorder
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02



Possible Zyprexa side effects in female

Reported by a physician from France on 2012-05-15

Patient: female, weighing 74.0 kg (162.8 pounds)

Reactions: Hypercholesterolaemia, Pneumonia Aspiration, Type 2 Diabetes Mellitus, Central Obesity, Hyponatraemia, Pyrexia, Hypertension, Hypertriglyceridaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Zyprexa

Other drugs received by patient: Zopiclone



Possible Zyprexa side effects in male

Reported by a consumer/non-health professional from United States on 2012-04-27

Patient: male

Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Inappropriate Schedule of Drug Administration, Back Pain, Dysphagia, Dystonia, Grimacing, Abnormal Behaviour, Condition Aggravated, Torticollis, Muscle Twitching, Dissociation, Extrapyramidal Disorder, Gait Disturbance, Tardive Dyskinesia, Hypertension

Drug(s) suspected as cause:
Risperdal Consta
    Indication: Major Depression
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Indication: Bipolar Disorder
    Start date: 2009-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-04-07
    End date: 2011-02-02

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Zyprexa
    Indication: Schizophrenia

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02

Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02



Possible Zyprexa side effects in 56 year old female

Reported by a consumer/non-health professional from Sweden on 2012-04-25

Patient: 56 year old female

Reactions: Death, LIP and / or Oral Cavity Cancer, Pneumonia, Empyema, Multiple Sclerosis, Hypertension

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Zyprexa
    Dosage: 10 mg, qd
    Administration route: Oral
    Indication: Bipolar Disorder
    End date: 2011-11-12

Olanzapine
    Dosage: unk
    Indication: Bipolar Disorder
    Start date: 2011-11-16

Other drugs received by patient: Seroquel; Lithionit; Seroquel



Possible Zyprexa side effects in male

Reported by a consumer/non-health professional from United States on 2012-04-05

Patient: male

Reactions: Movement Disorder, Weight Decreased, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Gait Disturbance, Extrapyramidal Disorder, Tardive Dyskinesia, Hypertension

Drug(s) suspected as cause:
Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Indication: Bipolar Disorder
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2009-01-01

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Indication: Major Depression
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Zyprexa
    Indication: Schizophrenia

Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01



Possible Zyprexa side effects in male

Reported by a consumer/non-health professional from United States on 2012-03-23

Patient: male, weighing 95.3 kg (209.6 pounds)

Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Dystonia, Grimacing, Abnormal Behaviour, Condition Aggravated, Torticollis, Muscle Twitching, Dissociation, Gait Disturbance, Tardive Dyskinesia, Hypertension

Drug(s) suspected as cause:
Risperdal Consta
    Dosage: every 4 to 6 weeks
    Indication: Bipolar Disorder
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Indication: Major Depression
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2009-01-01

Zyprexa
    Indication: Schizophrenia

Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Risperdal Consta
    Dosage: ndc 050468-306

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Dosage: ndc 050468-306

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal Consta
    Dosage: ndc 050468-306

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01



Possible Zyprexa side effects in 88 year old female

Reported by a physician from France on 2012-03-21

Patient: 88 year old female

Reactions: Confusional State, Abnormal Behaviour, Hypertension, Aggression

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Zyprexa
    Dosage: 5 mg, qd
    Administration route: Oral
    Start date: 2012-01-11
    End date: 2012-01-20

Zyprexa
    Dosage: 5 mg, qd
    Start date: 2012-01-24

Other drugs received by patient: Vitamin D; Oxazepam; Memantine Hydrochloride; Memantine Hydrochloride; Moviprep; Furadantin; Aspirin; Mirtazapine; Imovane; Escitalopram Oxalate; Acetaminophen



Possible Zyprexa side effects in female

Reported by a physician from Croatia (Local Name: Hrvatska) on 2012-03-14

Patient: female, weighing 100.0 kg (220.0 pounds)

Reactions: Off Label Use, Tachycardia, General Physical Health Deterioration, Pulmonary Oedema, Hypertension

Adverse event resulted in: death

Drug(s) suspected as cause:
Zyprexa

Other drugs received by patient: Zonadin; Diazepam; Lanitop; Equanil; Depakene; Iruzid / 06400701 /



Possible Zyprexa side effects in male

Reported by a consumer/non-health professional from United States on 2012-03-12

Patient: male, weighing 95.3 kg (209.6 pounds)

Reactions: Weight Decreased, Movement Disorder, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Tardive Dyskinesia, Hypertension

Drug(s) suspected as cause:
Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Indication: Major Depression
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: ndc 050468-306

Risperdal Consta
    Start date: 2009-01-01

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Zyprexa
    Indication: Schizophrenia

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: ndc 050468-306

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Indication: Bipolar Disorder
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Dosage: ndc 050468-306



Possible Zyprexa side effects in male

Reported by a physician from United States on 2012-03-08

Patient: male

Reactions: Blood Alkaline Phosphatase Increased, Gingivitis, Cellulitis, Diabetes Mellitus, Tooth Infection, Rash, Onychomycosis, Wound Haemorrhage, Weight Increased, Hyperlipidaemia, Overdose, Tardive Dyskinesia, Sinusitis, Hypertension, Hepatitis B

Drug(s) suspected as cause:
Zyprexa
    Dosage: 5 mg, prn
    Administration route: Oral
    Indication: Schizophrenia

Zyprexa
    Dosage: 20 mg, each evening
    Administration route: Oral

Zyprexa
    Dosage: 15 mg, each evening

Other drugs received by patient: Topamax; Topiramate; Celexa; Seroquel; Abilify; Geodon; Fosamax; Hydroxyzine; Clozaril; Forteo



Possible Zyprexa side effects in 56 year old female

Reported by a consumer/non-health professional from Sweden on 2012-03-08

Patient: 56 year old female

Reactions: Death, LIP and / or Oral Cavity Cancer, Pneumonia, Empyema, Multiple Sclerosis, Hypertension

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Zyprexa
    Dosage: 10 mg, qd
    Administration route: Oral
    Indication: Bipolar Disorder
    End date: 2011-11-12

Olanzapine
    Indication: Bipolar Disorder

Other drugs received by patient: Seroquel; Lithionit; Seroquel



Possible Zyprexa side effects in female

Reported by a consumer/non-health professional from United States on 2012-03-08

Patient: female

Reactions: Hypertrophic Cardiomyopathy, Prinzmetal Angina, Ear Infection, Coronary Artery Disease, Hyperlipidaemia, Neuropathy Peripheral, Dizziness, Type 1 Diabetes Mellitus, Acute Coronary Syndrome, Hypertension, Acute Myocardial Infarction, Gastrooesophageal Reflux Disease, Metabolic Syndrome

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Zyprexa

Other drugs received by patient: Amitriptyline HCL; Lotension; Triavil; Haldol; Diltiazem HCL



Possible Zyprexa side effects in female

Reported by a physician from United States on 2012-03-05

Patient: female

Reactions: Pancreatitis Acute, Diabetes Mellitus, Haematuria, Renal Cyst, Weight Increased, Renal Failure, Pancreatitis, Diabetic Ketoacidosis, Sleep Apnoea Syndrome, Hypertension

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Zyprexa

Other drugs received by patient: Advair Diskus 100 / 50; Lexapro



Possible Zyprexa side effects in male

Reported by a consumer/non-health professional from United States on 2012-03-05

Patient: male

Reactions: Akathisia, Glomerulonephritis Chronic, Type 2 Diabetes Mellitus, Hallucination, Auditory, Suicidal Ideation, Weight Increased, Hyperlipidaemia, Homicidal Ideation, Gastrooesophageal Reflux Disease, Hypertension, Head Titubation

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Zyprexa
    Dosage: 5 mg, each evening
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2002-10-02

Zyprexa
    Dosage: 15 mg, each evening
    Administration route: Oral
    End date: 2005-01-01

Zyprexa
    Dosage: 20 mg, each evening
    Administration route: Oral

Zyprexa
    Dosage: 10 mg, each evening
    Administration route: Oral

Other drugs received by patient: Benztropine Mesylate; Haldol; Benzodiazepine Derivatives; Risperdal; Klonopin; Venlafaxine HCL



Possible Zyprexa side effects in male

Reported by a consumer/non-health professional from United States on 2012-03-02

Patient: male, weighing 95.3 kg (209.6 pounds)

Reactions: Weight Decreased, Movement Disorder, Pain, Quality of Life Decreased, Muscle Tightness, Neck Pain, Social Avoidant Behaviour, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Inappropriate Schedule of Drug Administration, Back Pain, Dysphagia, Dystonia, Grimacing, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Tardive Dyskinesia, Hypertension

Drug(s) suspected as cause:
Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Indication: Major Depression
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Dosage: ndc 050468-306

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Zyprexa
    Indication: Schizophrenia

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2009-01-01

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal Consta
    Indication: Bipolar Disorder
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Dosage: ndc 050468-306

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: ndc 050468-306

Risperdal Consta
    Start date: 2009-01-01



Possible Zyprexa side effects in female

Reported by a consumer/non-health professional from United States on 2012-02-27

Patient: female

Reactions: Diabetes Mellitus, Pancreatic Carcinoma, Hypoglycaemia, Vaginal Haemorrhage, Hyperlipidaemia, Syncope, Chest Pain, Pancreatitis, Hypertension

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Zyprexa

Other drugs received by patient: Zoloft; Cogentin; Trazodone HCL; Haldol



Possible Zyprexa side effects in

Reported by a consumer/non-health professional from United States on 2012-02-23

Patient:

Reactions: Drug Ineffective, Tinea Versicolour, Oral Herpes, Tinea Pedis, Viith Nerve Paralysis, Dermatitis Contact, Weight Increased, Upper Respiratory Tract Infection, Liver Function Test Abnormal, Type 1 Diabetes Mellitus, Gastrooesophageal Reflux Disease, Pain in Extremity, Tinea Cruris, non-Cardiac Chest Pain, Convulsion, Hyperlipidaemia, Pericarditis, Bronchitis, Sinus Tachycardia, Hypertension

Drug(s) suspected as cause:
Zyprexa

Other drugs received by patient: Paxil; Prozac; Clonidine; Haldol; Doxepin HCL; Valproic Acid; Remeron; Geodon; Aspirin; Risperdal; Ativan; Stelazine; Depakote; Nortriptyline Hydrochloride



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017